Base Excision Repair
Nucleotide Excision Repair
DNA Damage can Stall the Cell Cycle
Long-patch Base Excision Repair
Targeted Cancer Therapies
Fixing Double-strand Breaks
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 9, 2025

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
Vakil Takhaveev1, Kook Son2, Visesato Mor2
1Department of Health Sciences and Technology, ETH Zürich, CH-8092 Zürich, Switzerland. vakil.takhaveev@hest.ethz.ch.
Trabectedin is a potent anticancer drug that targets cancer cells with active DNA repair, specifically transcription-coupled nucleotide excision repair (TC-NER). This study visualizes TC-NER genome-wide, revealing how trabectedin induces DNA breaks in active genes.
06:59Using Next Generation Sequencing to Identify Mutations Associated with Repair of a CAS9-induced Double Strand Break Near the CD4 Promoter
Published on: March 31, 2022
06:44Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: